Instruction for use: Timoptic-depo

Active substance Timolol

ATX Code S01ED01 Timolol

Pharmacotherapeutic group:

Beta-blockers

Ophthalmic agents

The nosological classification (ICD-10)

H40.0 Suspected glaucoma

Marked rise in intraocular pressure, Hypertension eyes, ocular hypertension, Measurement of intraocular pressure, ophthalmohypertension, Elevated IOP, Elevated intraocular pressure, Elevated intraocular pressure in infectious diseases of the eye, Povyshennore intraocular pressure, Increased ophthalmotonus, Spontaneous blockade angle opposite eye, Narrow chamber angle, Iatrogenic, blockade angle opposite eye

H40.1 Primary open-angle glaucoma

open-angle glaucoma, Open-angle glaucoma, Primary glaucoma, pseudoexfoliation glaucoma, Elevated IOP

H40.5 Glaucoma secondary to other eye diseases

The secondary open-angle glaucoma, Glaucoma afakicheskaya, Secondary glaucoma

Structure and Composition

1 ml gel solution containing timolol maleate 2.5 or 5 mg; in vials of 2.5 ml; in box 1 bottle.

pharmachologic effect

antiglaucoma.

Beta-adrenoceptor blocking.

Clinical pharmacology

The action develops quickly - 20 minutes after instillation. The maximum intraocular pressure reduction observed after 2-4 hours, the effect lasts for 24 hours.

Indications

Elevated intraocular pressure: ocular hypertension, glaucoma (chronic open, secondary, combined with aphakia with narrow anterior chamber angles, with spontaneous or iatrogenic narrow angle by closing the opposite eye).

Contraindications

Hypersensitivity, bronchial asthma (including in history), and others. Chronic obstructive pulmonary disease, sinus bradycardia, AV block II-III degree, expressed heart failure, cardiogenic shock, child.

Pregnancy and breast-feeding

The caution (for health reasons).

Side effects

Blurred vision (for 1 / 2-5 minutes after instillation), pain, burning, soreness, itching and foreign body sensation in the eye, lacrimation and increased discharge from the eyes, conjunctivitis, blepharitis, keratitis, blurred vision, diplopia, ptosis; because the drug can be absorbed from the conjunctival sac into the systemic circulation, there may be headache, dizziness, bradycardia, heart block, cardiac arrest, hypotension, syncope, cerebrovascular accident, heart failure, bronchospasm, asthenia, myasthenia gravis, depression, nausea; allergic reactions.

Dosing and Administration

Kongungualno, 1 drop every day 1 (0.5% solution was more pronounced effect is used as necessary).

Storage conditions

In the dark place at a temperature no higher than 25 ° C (do not freeze).

Keep out of the reach of children.